key: cord-0781448-f2gte5s1
authors: Braun, K. M.; Moreno, G. K.; Buys, A.; Bobholz, M.; Accola, M. A.; Anderson, L.; Rehrauer, W. M.; Baker, D. A.; Safdar, N.; Lepak, A. J.; O'Connor, D.; Friedrich, T.
title: Viral sequencing reveals US healthcare personnel rarely become infected with SARS-CoV-2 through patient contact
date: 2021-02-01
journal: nan
DOI: 10.1101/2021.01.28.21250421
sha: eca066a5b1ed9995f34303e2bae4384125ccb820
doc_id: 781448
cord_uid: f2gte5s1

Background Healthcare personnel (HCP) are at increased risk of infection with the severe acute respiratory coronavirus 2019 virus (SARS-CoV-2). Between 12 March 2020 and 10 January 2021, >1,170 HCP tested positive for SARS-CoV-2 at a major academic medical institution in the Upper Midwest of the United States. We aimed to understand the sources of infections in HCP and to evaluate the efficacy of infection control procedures used at this institution to protect HCP from healthcare-associated transmission. Methods In this retrospective case series, we used viral genomics to investigate the likely source of SARS-CoV-2 infection in 96 HCP where epidemiological data alone could not be used to rule out healthcare-associated transmission. We obtained limited epidemiological data through informal interviews and review of the electronic health record. We combined viral sequence data and available epidemiological information to infer the most likely source of HCP infection. Findings We investigated 32 SARS-CoV-2 infection clusters involving 96 HCP, 140 possible patient contacts, and 1 household contact (total n = 237). Of these, 182 sequences met quality standards and were used for downstream analysis. We found the majority of HCP infections could not be linked to a patient or co-worker and therefore likely occurred in the outside community (58/96; 60.4%). We found a smaller percentage could be traced to a coworker (10/96; 10.4%) or were part of a patient-employee cluster (12/96; 12.5%). Strikingly, the smallest proportion of HCP infections could be clearly traced to a patient source (4/96; 4.2%). Interpretation Infection control procedures, consistently followed, offer significant protection to HCP caring for COVID-19 patients in a representative American academic medical institution. Rapid SARS-CoV-2 genome sequencing in healthcare settings can be used retrospectively to reconstruct the likely source of HCP infection when epidemiological data are not available or are inconclusive. Understanding the source of SARS-CoV-2 infection can then be used prospectively to adjust and improve infection control practices and guidelines.

*These authors contributed equally 18 # These authors contributed equally 19 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In this retrospective case series, we used viral genomics to investigate the likely source of 30 SARS-CoV-2 infection in 96 HCP where epidemiological data alone could not be used to rule 31 out healthcare-associated transmission. We obtained limited epidemiological data through 32 informal interviews and review of the electronic health record. We combined viral sequence data 33 and available epidemiological information to infer the most likely source of HCP infection. 34 35 Findings 36 We investigated 32 SARS-CoV-2 infection clusters involving 96 HCP, 140 possible patient 37 contacts, and 1 household contact (total n = 237). Of these, 182 sequences met quality 38 standards and were used for downstream analysis. We found the majority of HCP infections 39 could not be linked to a patient or co-worker and therefore likely occurred in the outside 40 community (58/96; 60.4%). We found a smaller percentage could be traced to a coworker 41 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 1, 2021. ; https://doi.org/10.1101/2021.01.28.21250421 doi: medRxiv preprint 3 (10/96; 10.4%) or were part of a patient-employee cluster (12/96; 12.5%). Strikingly, the 42 smallest proportion of HCP infections could be clearly traced to a patient source (4/96; 4.2%). On 16 January 2021 we searched for "SARS-CoV-2" AND "healthcare workers" AND "viral 60 sequencing" in Google Scholar. This search returned 57 results, and included a number of 61 preprint articles. We found two studies that used viral sequencing to investigate healthcare-62 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) infection with SARS-COV-2 12 . These guidelines include recommendations for the proper use of 104 PPE, hand hygiene, precautions to be taken during aerosol-generating procedures, collection of 105 diagnostic respiratory specimens, environmental infection control practices and many others. 106

These guidelines in addition to institution-specific infection control measures -described in 107 detail in Lepak et al 13 -were in place at the institution evaluated here. We posit that these 108 guidelines are generally successful in protecting HCP from SARS-CoV-2 infection in a 109 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 1, 2021. ; https://doi.org/10.1101/2021.01.28.21250421 doi: medRxiv preprint 6 healthcare setting. In this report, we test this hypothesis using viral sequencing to investigate 110 the likely sources of infection in a series of HCP in the United States. 111 112 Sequencing has been used to explore the origin and the path of spread of various nosocomial 113 bacterial pathogens, such as vancomycin resistant-enterococcus (VRE), Listeria 114 monocytogenes, and Klebsiella pneumoniae [14] [15] [16] [17] . With a few exceptions [18] [19] [20] , viral sequencing 115 is not currently standard practice for investigating healthcare-associated SARS-CoV-2 116 infections, although we and others have highlighted the potential utility of this approach 3-6 . Data 117 suggest SARS-CoV-2 accumulates approximately one fixed mutation every other transmission 118 event 21, 22 . Therefore, if SARS-CoV-2 is directly transmitted from one individual to another, this 119 "transmission pair" is expected to share identical, or nearly identical (≤1 consensus SNV 120 difference), viral sequences. The most parsimonious explanation for identical or near-identical 121 genomes generated from individuals with known contact is that they are transmission pairs 23 . In 122 contrast, two people who became infected at similar times, but from different sources, would be 123 expected to be infected with viruses that differ from each other by two or more nucleotides. This 124 is especially true at this stage of the pandemic in the United States, when transmission rates are 125 high and multiple viruses of distinct genetic lineages cocirculate in many areas 24 . By increasing 126 the resolution of inference, rapid viral sequencing can facilitate a targeted approach to examine 127 SARS-CoV-2 nosocomial outbreaks at the level of the individual and the institution, which others 128 have referred to collectively as "precision epidemiology" 25 . 129

HCP began testing positive for SARS-CoV-2 at a major academic biomedical institution in the 131 American Upper Midwest in early March 2020. From 12 March, 2020 to 10 January, 2021 132 ~1,172 HCP tested positive for SARS-CoV-2 at this center. In collaboration with this institution's 133 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 1, 2021. ; https://doi.org/10.1101/2021.01.28.21250421 doi: medRxiv preprint infection control team, we began sequencing viral genomes from residual nasopharyngeal 134 specimens from the individuals involved in these infection clusters. We focused our analyses on 135 HCP infections and infection clusters that were highest risk for nosocomial transmission, as 136 when healthcare-associated transmission could not be ruled out using epidemiological data 137 alone. Each investigation included at least one HCP, all known direct and indirect SARS-CoV-2-138 positive patient contacts where residual swab was available, and occasionally extended to 139 epidemiologically-linked household contacts. Relevant patient contacts were identified in the 140 Epic electronic medical record using a comprehensive caregiver trace. This function identifies all 141 patient records accessed by a HCP. 142

We consider three main potential sources of healthcare-associated infection with SARS-CoV-2: 144 "outside community," "patient source" (via HCP-patient interactions), and "employee source" (via 145 HCP-HCP interactions). A few HCP infections did not fit neatly into these categories so we have 146 included two additional categories. First, "combined patient and employee cluster", where a 147 patient-to-HCP transmission event likely initiated a cluster of infections, but we were unable to 148 pinpoint the first HCP to become infected. Second, "inconclusive", where a consensus 149 sequence was not available, there were no appropriate comparator samples, or epidemiological 150 information were insufficient to interpret the sequence data. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 1, 2021. ; https://doi.org/10.1101/2021.01.28.21250421 doi: medRxiv preprint 8 In total, we investigated 32 SARS-CoV-2 infection clusters involving 96 HCP, 140 possible 160 patient contacts, and 1 household contact (total n = 237). This accounted for approximately 161 ~8.2% (96/1,172) of all documented infections in the HCP at this institution. In total, we 162 sequenced 237 samples collected between 15 March and 27 December, 2020. Of these, 182 163 met quality standards (as described in methods) and were used for downstream analysis. We 164 did not find a closely related virus among the epidemiologically linked contacts in 58 HCP 165 infections, so we concluded the most likely source of infection in these cases could be traced to 166 the outside community (58/96; 60.4%). We find a smaller percentage could be traced to a 167 coworker (10/96; 10.4%) or were part of a patient-employee cluster (12/96; 12.5%). Strikingly, 168 the smallest proportion of HCP infections could be clearly traced to a patient source (4/96; 169 4.2%). The remaining HCP infections could not be definitively traced to a single source and 170 were therefore inconclusive (12/96; 12.5%) ( Table 1) was infected with a 20A-clade virus. The sequences of these viruses differed at >20 sites, so we 182 concluded these individuals were unlikely to represent a transmission pair and HCP 20-1 was 183 more likely infected in the outside community (Figure 1) . 184 185 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. protecting HCP, teachers, children, workers, and individuals who are incarcerated. We should 257 work to build such systems now because we can be certain pathogenic viruses will continue to 258 emerge unpredictably. 259 260 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 1, 2021. Complementary DNA (cDNA) was synthesized using a modified ARTIC Network approach 28,29 . 325

Briefly, vRNA was reverse transcribed with SuperScript IV Reverse Transcriptase (Invitrogen,  326 Carlsbad, CA, USA) using random hexamers and dNTPs. Reaction conditions were as follows: 327 1μL of random hexamers and 1µL of dNTPs were added to 11 μL of sample RNA, heated to 328 65˚C for 5 minutes, then cooled to 4˚C for 1 minute. Then 7 μL of a master mix (4 μL 5x RT 329 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 1, 2021. ; https://doi.org/10.1101/2021.01.28.21250421 doi: medRxiv preprint buffer, 1 μL 0.1M DTT, 1µL RNaseOUT RNase Inhibitor, and 1 μL SSIV RT) was added and 330 incubated at 42˚C for 10 minutes, 70˚C for 10 minutes, and then 4˚C for 1 minute. 331

Multiplex PCR to generate SARS-CoV-2 genomes 332 A SARS-CoV-2-specific multiplex PCR for Nanopore sequencing was performed, similar to 333 amplicon-based approaches as previously described 28, 29 . In short, primers for 96 overlapping 334 amplicons spanning the entire genome with amplicon lengths of 500bp and overlapping by 75 to 335 100bp between the different amplicons were used to generate cDNA. cDNA (2.5 μL) was 336 amplified in two multiplexed PCR reactions using Q5 Hot-Start DNA High-fidelity Polymerase 337 (New England Biolabs, Ipswich, MA, USA) using the conditions previously described 28, 29 . 338

Samples were amplified through 25 cycles of PCR and each resulting multiplex sample was 339 pooled together before ONT library prep. 340

Library preparation and sequencing 341 Amplified PCR product was purified using a 1:1 concentration of AMPure XP beads (Beckman 342

Coulter, Brea, CA, USA) and eluted in 30μL of water. PCR products were quantified using Qubit 343 dsDNA high-sensitivity kit (Invitrogen, USA) and were diluted to a final concentration of 1 ng/μl. 344 A total of 5ng for each sample was then made compatible for deep sequencing using the one-345 pot native ligation protocol with Oxford Nanopore kit SQK-LSK109 and its Native Barcodes 346 (EXP-NBD104 and EXP-NBD114) 29 . Specifically, samples were end-repaired using the 347 NEBNext Ultra II End Repair/dA-Tailing Module (New England Biolabs, Ipswich, MA, USA). 348

Samples were then barcoded using 2.5µL of ONT Native Barcodes and the Ultra II End Repair 349

Module. After barcoding, samples were pooled directly into a 1:1 concentration of AMPure XP 350 beads (Beckman Coulter, Brea, CA, USA) and eluted in 30µL of water. Samples were then 351 tagged with ONT sequencing adaptors according to the modified one-pot ligation protocol 29 . Up 352 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 1, 2021. For each sample set, we drafted these results into a PDF report to be shared with the hospital 387 infection control team. These reports were drafted in a standardized format. In each report, we 388 outlined the purpose for the report, the samples involved including any associated metadata, a 389 brief description of the methods used to generate the sequence data, a screen grab of a 390

Nextclade alignment, a table summarizing the iSNV differences, phylogenetic trees if applicable, 391 and finally any overall conclusions that could be drawn regarding the likely and unlikely sources 392 of infection. A summary of each of these reports can be found in Supplementary File 1. 393 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 1, 2021. We gratefully acknowledge Anna Heffron for assisting with sample transport. We also thank all 407 healthcare workers and infection control teams for their ongoing dedication to patient and 408 community health and wellness. This project was funded in part through COVID-19 Response CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 1, 2021. ; https://doi.org/10.1101/2021.01.28.21250421 doi: medRxiv preprint Table 1 . Summary of the likely source of infection in the HCP evaluated in this study. 508 509 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 1, 2021. ; https://doi.org/10.1101/2021.01.28.21250421 doi: medRxiv preprint

COVID-19 in health-care workers in three 415 hospitals in the south of the Netherlands: a cross-sectional study

Rapid implementation of SARS-CoV-2 418

sequencing to investigate cases of health-care associated COVID-19: a prospective genomic 419 surveillance study

Application of next generation sequencing 421 in clinical microbiology and infection prevention

Infection control in the new age of 423 genomic epidemiology

Using Virus Sequencing to 425

Determine Source of SARS-CoV-2 Transmission for Healthcare Worker

Serologic Surveillance and Phylogenetic Analysis of 428

SARS-CoV-2 Infection in Hospital Health Care Workers

Risk of COVID-19 among front-line health-care 430 workers and the general community: a prospective cohort study

Epidemiology of and Risk Factors for 433

Coronavirus Infection in Health Care Workers: A Living Rapid Review

Factors Associated With Mental Health Outcomes Among Health 436

Care Workers Exposed to Coronavirus Disease

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

Estimating Coronavirus Disease

Health Care Workers

Factors Among the Health Care Workers Exposed to the COVID-19

Interim Infection Prevention and Control Recommendations for Healthcare Personnel 443

During the Coronavirus Disease 2019 (COVID-19) Pandemic

Implementation of infection control 445 measures to prevent healthcare-associated transmission of severe acute respiratory 446 coronavirus virus 2 (SARS-CoV-2)

Whole-Genome Sequencing of Bacterial 448 Pathogens: the Future of Nosocomial Outbreak Analysis

Outbreak Breakthrough: Using Whole-Genome Sequencing to Control Hospital 451

Clostridium difficile: Investigating Transmission Patterns 453

Between Infected and Colonized Patients Using Whole Genome Sequencing

Tracking a hospital outbreak of carbapenem-456 resistant Klebsiella pneumoniae with whole-genome sequencing

Use of Whole-Genome Sequencing of 459

Adenovirus in Immunocompromised Pediatric Patients to Identify Nosocomial Transmission and 460

Mixed-Genotype Infection

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

Rapid Metagenomic Next-Generation Sequencing 462 during an Investigation of Hospital-Acquired Human Parainfluenza Virus 3 Infections

Use of Whole-Genome Sequencing in the 465

Investigation of a Nosocomial Influenza Virus Outbreak

Measurably evolving pathogens in the 467 genomic era

Estimates of serial interval for COVID-19: A systematic review 469 and meta-analysis

Genomic analysis of COVID-19

Genomic epidemiology of novel coronavirus -North America-focused 473 subsampling

Precision epidemiology for infectious 475 disease control

School closure and management practices during 477 coronavirus outbreaks including COVID-19: a rapid systematic review

Reopening Primary Schools during the Pandemic. N Engl 480

Multiplex PCR method for MinION and Illumina 482 sequencing of Zika and other virus genomes directly from clinical samples

nCoV-2019 sequencing protocol

Nextstrain: real-time tracking of pathogen evolution

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted February 1, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 1, 2021. ; https://doi.org/10.1101/2021.01.28.21250421 doi: medRxiv preprint